In addition, pharmacological inhibition of CCL2 by the RNA-aptamer mNOX-E36 attenuates liver fibrosis, thereby strengthening a profibrotic function of Ly6Chigh macrophages (83, 84). Here, CCL2 is linked to Hepatic fibrosis.